OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.525
-0.025 (-0.98%)
May 27, 2026, 12:19 PM EDT - Market open
OmniAb Market Cap
OmniAb has a market cap or net worth of $366.06 million as of May 27, 2026. Its market cap has increased by 90.59% in one year.
Market Cap
366.06M
Enterprise Value
340.28M
1-Year Change
90.59%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $366.06M, a decrease of -63.13%. That is a compound annual growth rate of -24.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 384.18M | 44.26% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 384.53M |
| Verastem | 383.13M |
| Lyell Immunopharma | 380.70M |
| Replimune Group | 379.83M |
| Greenwich LifeSciences | 379.48M |
| X4 Pharmaceuticals | 377.28M |
| Vanda Pharmaceuticals | 374.04M |
| Artiva Biotherapeutics | 372.67M |